Sagimet Biosciences Inc.
SGMT
$10.55
$1.2713.69%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 240.13M | 104.54M | 113.12M | 116.69M | 125.41M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.20M | 2.53M | 2.80M | 2.29M | 996.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 660.00K | 650.00K | 481.00K | 500.00K | 793.00K |
| Total Current Assets | 243.99M | 107.72M | 116.40M | 119.48M | 127.20M |
|
|
|||||
| Total Current Assets | 243.99M | 107.72M | 116.40M | 119.48M | 127.20M |
| Net Property, Plant & Equipment | 1.95M | 39.00K | 78.00K | 115.00K | 152.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 55.00K | -- | -- | -- | -- |
| Total Assets | 263.43M | 107.76M | 116.48M | 128.40M | 137.41M |
|
|
|||||
| Total Accounts Payable | 1.13M | 2.30M | 1.31M | 4.24M | 1.92M |
| Total Accrued Expenses | 4.18M | 2.94M | 3.69M | 4.78M | 5.17M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 84.00K | 39.00K | 78.00K | 115.00K | 152.00K |
| Total Finance Division Other Current Liabilities | 26.00K | 15.00K | 27.00K | 8.00K | 1.00K |
| Total Other Current Liabilities | 26.00K | 15.00K | 27.00K | 8.00K | 1.00K |
| Total Current Liabilities | 5.42M | 5.30M | 5.10M | 9.15M | 7.25M |
|
|
|||||
| Total Current Liabilities | 5.42M | 5.30M | 5.10M | 9.15M | 7.25M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.86M | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.28M | 5.30M | 5.10M | 9.15M | 7.25M |
|
|
|||||
| Common Stock & APIC | 627.18M | 459.45M | 457.61M | 455.92M | 453.96M |
| Retained Earnings | -370.95M | -357.00M | -346.35M | -336.78M | -323.87M |
| Treasury Stock & Other | -77.00K | 8.00K | 120.00K | 117.00K | 76.00K |
| Total Common Equity | 256.16M | 102.46M | 111.38M | 119.26M | 130.16M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 256.16M | 102.46M | 111.38M | 119.26M | 130.16M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 256.16M | 102.46M | 111.38M | 119.26M | 130.16M |
|
|
|||||